POLYCYSTIC KIDNEY DISEASE
POLYCYSTIC KIDNEY DISEASE
- It is a genetic disorder, resulting in the development and growth of multiple cysts within the kidney
- Autosomal dominant polycystic kidney disease (ADPKD) - 75% Chances of expression in next generation
- Autosomal recessive polycystic kidney disease (ARPKD) - 25% Chances of expression in next generation
- chromosome 16 PKD1 gene defect - polycystin 1 protein affected
- chromosome 4 PKD2 gene defect - polycystin 2 protein affected
- Multiple cysts present both in medulla and cortex
- Renomegaly and progressive development of cyst occurs
- Development of bleeding in cyst can occur and which can cause flank pain
CLINICAL FEATURE:
Usual age of presentation = 30 -45 years
- Flank pain (due to stone formation, bleeding in cyst )
- UTI(urinary tract infection): higher (chance of pyelonephritis)
- stones incidence higher : Urate stones
- can develop Renal cell cancer (RCC) : Bilateral, multicentric
- GFR decreased ( due to cyst)
- renin concentration increasing → retention of sodium → hypertension(headache)
EXTRA RENAL MANIFESTATION:
- Liver cyst (lined by biliary endothelium)
spleen cyst
- CNS - Berry aneurysm → subarachnoid hemorrhage → headache
- CVS - Mitral valve prolapse , tricuspid regurgitation
- GIT - Colonic diverticulosis (constipation)
WORKUP:
- CT abdomen / USG
- T2 Weighted imaging in MRI
- DOC for contrast induced nephropathy - N - Acetyl cysteine and supportive therapy with IV Fluids
- KFT(kidney function test) - to check BUN/creatinine
- serum electrolyte: k+ increased in stage 3 and 4 CKD
- Genetic linkage study: to identify gene involved
- MR Angiography head, Echocardiography, Ba enema
TREATMENT:
- Control hypertension = ACE inhibitors/ARB'S
(Target BP 130/80 mm Hg in CKD)
- Lipid soluble antibiotics = cotrimoxazole,Quinolones
- Analgesia for relieving pain, because - colonic diverticulosis,flank pain
- Transcutaneous electrical nerve pacing
- kidney transplant is recommended in stage 4 patients
- pre transplant nephrectomy
- sirolimus(mTOR INHIBITOR) - inhibit cell proliferation and can reduce progressive of cyst
- Tolvaptan (v2 antagonist)/octreotide (long acting) - slow the decline of renal function





Comments
Post a Comment